表紙
市場調查報告書

女性用避孕藥:全球臨床實驗趨勢分析 (2020年前半期)

Female Contraception Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 929728
出版日期 內容資訊 英文 409 Pages
訂單完成後即時交付
價格
女性用避孕藥:全球臨床實驗趨勢分析 (2020年前半期) Female Contraception Global Clinical Trials Review, H1, 2020
出版日期: 2020年03月06日內容資訊: 英文 409 Pages
簡介

本報告提供女性用避孕藥相關臨床實驗最新趨勢分析,彙整疾病·治療方法概要,及G7/E7各國 (主要已開發國家·新興國家) 的臨床實驗狀況,各地區·階段·各期的進展,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

  • 本報告概要
  • 分析範圍
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區的臨床實驗數量:主要5個國家
      • 歐洲臨床實驗數量:主要5個國家
      • 北美:主要國家的臨床實驗數量
      • 中東·非洲:主要國家的臨床實驗數量
      • 中南美:主要國家的臨床實驗數量
  • G7各國臨床實驗數量:女性用避孕藥 - 婦產科整體佔比
  • G7各國臨床實驗數量:各期
  • G7各國臨床實驗數量:各臨床實驗階段
  • E7各國臨床實驗數量:女性用避孕藥 - 婦產科整體佔比
  • E7各國臨床實驗數量:各期
  • E7各國臨床實驗數量:各臨床實驗階段
  • 臨床實驗數量:各期
    • 現在進行中的臨床實驗數量:各期
  • 臨床實驗數量:各進展狀況
  • 臨床實驗數量:各評估項目
  • 一定期間所採用的受驗人數
  • 臨床實驗數量:贊助商類別
  • 有潛力的贊助商
    • 參加女性用避孕藥臨床實驗的大企業
  • 有潛力的醫藥品
  • 臨床實驗簡介的基本資料
  • 附錄
目錄
Product Code: GDHC6178CTIDB

GlobalData's clinical trial report, "Female Contraception Global Clinical Trials Review, H1, 2020" provides an overview of Female Contraception Clinical trials scenario. This report provides top line data relating to the clinical trials on Female Contraception. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Female Contraception to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Female Contraception to Women's Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Female Contraception Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
  • Source

List of Tables

  • Female Contraception Therapeutics, Global, Clinical Trials by Region, 2020*
  • Female Contraception Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Female Contraception Therapeutics, Global, Clinical Trials

List of Figures

  • Female Contraception Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Female Contraception Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Female Contraception Therapeutics, Global, Clinical T